According to the Food and Drug Administration (FDA), Bristol-Myers Squibb announced an update to the U.S. labeling for Tequin (gatifloxacin) tablets and injection on February 15, 2006.

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

a drug–drug interaction via CYP seems highly unlikely, indicating that other mechanisms must be involved. Saraya et al. [31] studied the effect of levofloxacin, gatifloxacin, and temafloxacin on ...